Franco Caramia
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- Physiology top 5%
- Adenosine and Purinergic Signaling
Papers in
- Oncology 21
- Cancer Immunotherapy and Biomarkers 14
- CAR-T cell therapy research 6
- HER2/EGFR in Cancer Research 3
-
- Prostate Cancer Treatment and Research 6
- Prostate Cancer Diagnosis and Treatment 3
- Co-authors
- Ygal Haupt (14 shared papers)Sue Haupt (11 shared papers)Sherene Loi (19 shared papers)Sabra L. Klein (1 shared paper)Joshua B. Rubin (1 shared paper)Peter Savas (9 shared papers)Zhi L. Teo (6 shared papers)Phillip K. Darcy (8 shared papers)
- Journals
- Cancer Research (4 papers)Journal of Clinical Oncology (3 papers)Nature Communications (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- AustraliaUnited StatesBelgium
In The Last Decade
Franco Caramia
37 papers receiving 1.3k citations
Franco Caramia's Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 656
- Physiology 98
- Cancer Research 274
- Immunology 310
- Reproductive Medicine 120
Countries citing papers authored by Franco Caramia
This map shows the geographic impact of Franco Caramia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Caramia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Caramia more than expected).
Fields of papers citing papers by Franco Caramia
This network shows the impact of papers produced by Franco Caramia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Caramia. The network helps show where Franco Caramia may publish in the future.
Co-authors
The 25 scholars most cited alongside Franco Caramia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sex disparities matter in cancer development and therapy Hit paper breakdown → | 2021 | 196 |
| 2 | 2017 | 148 | |
| 3 | 2016 | 142 | |
| 4 | 2015 | 109 | |
| 5 | 2017 | 96 | |
| 6 | 2016 | 83 | |
| 7 | 2019 | 64 | |
| 8 | 2017 | 60 | |
| 9 | 2022 | 58 | |
| 10 | 2020 | 51 | |
| 11 | 2020 | 31 | |
| 12 | 2020 | 29 | |
| 13 | 2016 | 23 | |
| 14 | 2018 | 21 | |
| 15 | 2017 | 19 | |
| 16 | 2022 | 19 | |
| 17 | 2014 | 18 | |
| 18 | 2014 | 17 | |
| 19 | 2023 | 12 | |
| 20 | 2014 | 11 |
About Franco Caramia
Franco Caramia is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Cancer Research, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Cancer Genomics and Diagnostics (8 papers), Immunotherapy and Immune Responses (7 papers), Prostate Cancer Treatment and Research (6 papers), CAR-T cell therapy research (6 papers), HER2/EGFR in Cancer Research (3 papers), Prostate Cancer Diagnosis and Treatment (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Oncology (656 citations), Physiology (98 citations), Cancer Research (274 citations), Immunology (310 citations) and Reproductive Medicine (120 citations). Franco Caramia has collaborated with scholars based in Australia, United States and Belgium. Frequent co-authors include Ygal Haupt, Sue Haupt, Sherene Loi, Sabra L. Klein, Joshua B. Rubin, Peter Savas, Zhi L. Teo, Phillip K. Darcy, Paul J. Neeson and Grant A. McArthur. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Nature Communications, Journal for ImmunoTherapy of Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.